as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹3,717.6
Change
-18.7 (-0.5%)
Open
₹3,730.3
Prev. Close
₹3,736.3
Day High
₹3,759.7
Day Low
₹3,700.0
Volume Analysis
Traded
17,650
Delivered
9,256
Delivery %
52.44%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (0)
No signal for this stock
Weaknesses (2)
- •Trading within 3% of its 52-week low (₹3725.0)
- •Low operating margin (4.8%)
Opportunities (1)
- •FII holding has been rising
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹3,811.24 | ₹3,785.47 | ₹3,751.54 | ₹3,725.77 | ₹3,691.84 | ₹3,666.07 | ₹3,632.14 |
| Fibonacci | ₹3,785.47 | ₹3,762.66 | ₹3,748.58 | ₹3,725.77 | ₹3,702.96 | ₹3,688.88 | ₹3,666.07 |
| Camarilla | ₹3,734.02 | ₹3,728.55 | ₹3,723.07 | ₹3,725.77 | ₹3,712.13 | ₹3,706.66 | ₹3,701.18 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-18.17%
1 Week
-1.52%
1 Month
-8.18%
3 Months
-10.34%
6 Months
-21.63%
1 Year
-26.37%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹163.32
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
16.59%
Net margin 7.57% × asset turnover 0.8x × equity multiplier 2.74x
Company Overview
Sector
Chemicals
Market Cap
₹16,957 Cr
P/E (TTM)
344.0
ROE
15.8%
Book Value
₹84.5
Face Value
₹10.0
Source: Screener.in (Consolidated figures) — data as of 23 Sep 2026. Not investment advice.
TopFund Analysis
Bayer Cropscience Ltd lands in the middle of the pack on TopFund's composite fundamentals check within the Chemicals sector, at 54/100. The strongest factor is Financial Strength (98/100), while Momentum (3/100) is the weakest area to weigh before deciding. Notably: Trading within 3% of its 52-week low (₹3725.0); low operating margin (4.8%). FII holding has been rising.
TopFund Score — Fundamentals Quality
54/100 — AverageData confidence: 75/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Financial Strength
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- −Stock is trading at 44.7 times its book value
- −Company might be capitalizing the interest cost
- −Earnings include an other income of Rs.83.7 Cr.
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Trading window closed from October 1, 2026 until two days after Q2 FY2026 results.
Please find attached herewith the newspaper publication dated September 18, 2026, regarding opening of special window for transfer and dematerialization of physical securities pursuant ....
Pursuant to Regulation 30 and 47 read with Schedule III Part A Para A of SEBI (LODR) Regulations, 2015 we hereby enclose copies of newspaper …
Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 we hereby enclose copies of newspaper advertisement regarding intimation on loss …
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Dec 2005 | Dec 2006 | |
|---|---|---|
| Sales + | 223 | 242 |
| Expenses + | 194 | 225 |
| Operating Profit | 29 | 18 |
| OPM % | 13.0% | 7.0% |
| Other Income + | 7 | 18 |
| Interest | 2 | 3 |
| Depreciation | 6 | 6 |
| Profit before tax | 27 | 27 |
| Tax % | 71.0% | 36.0% |
| Net Profit + | 8 | 17 |
| EPS in Rs | 2 | 4 |
| Raw PDF | — | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Dec 2005 | Dec 2006 | |
|---|---|---|
| Sales + | 667 | 727 |
| Expenses + | 610 | 692 |
| Operating Profit | 57 | 35 |
| OPM % | 9.0% | 4.8% |
| Other Income + | 50 | 84 |
| Interest | 8 | 9 |
| Depreciation | 23 | 23 |
| Profit before tax | 77 | 87 |
| Tax % | 50.0% | 36.0% |
| Net Profit + | 38 | 55 |
| EPS in Rs | 10 | 14 |
| Dividend Payout % | 23.0% | 17.0% |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Dec 2005 | Dec 2006 | |
|---|---|---|
| Reserves | 250 | 294 |
| Borrowings + | 120 | 112 |
| Other Liabilities + | 436 | 468 |
| Total Liabilities | 846 | 914 |
| Fixed Assets + | 161 | 153 |
| CWIP | 8 | 4 |
| Investments | 4 | 4 |
| Other Assets + | 674 | 754 |
| Total Assets | 846 | 914 |
| Equity Capital | 40 | 40 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Dec 2005 | Dec 2006 | |
|---|---|---|
| Cash from Operating Activity + | -12 | 38 |
| Cash from Investing Activity + | -34 | -16 |
| Cash from Financing Activity + | 25 | -26 |
| Net Cash Flow | -21 | -4 |
| CFO/OP | 43 | 208 |
| Free Cash Flow | -56 | 21 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 12.05% | 12.33% | 12.15% | 12.47% | 13.18% | 13.45% | 13.53% | 13.55% | 13.56% | 13.27% | 12.79% | 12.96% |
| Promoters | 71.44% | 71.44% | 71.44% | 71.44% | 71.44% | 71.44% | 71.44% | 71.44% | 71.44% | 71.44% | 71.44% | 71.44% |
| FII | 3.3% | 3.53% | 3.62% | 3.63% | 3.3% | 3.42% | 3.49% | 3.64% | 3.8% | 3.84% | 3.89% | 3.97% |
| DII | 13.23% | 12.7% | 12.8% | 12.47% | 12.08% | 11.69% | 11.56% | 11.38% | 11.22% | 11.47% | 11.89% | 11.64% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Chemicals — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Bayer Cropscience Ltd (this stock) | 16,957 | 344.0 | 44.65 | 15.8% |
| Chambal Fertilizers Ltd | 16,839 | 8.72 | 1.62 | 20.0% |
| Supreme Petrochem Limited | 16,548 | 33.6 | 6.98 | 13.7% |
| Deepak Fertilizers & Petr | 17,490 | 17.8 | 2.56 | 10.9% |
| Tata Chemicals Ltd | 16,400 | — | 0.77 | 1.27% |
| Aarti Industries Ltd | 17,754 | 34.0 | 2.98 | 7.13% |
| Paradeep Phosphates Ltd | 16,148 | 14.9 | 2.37 | 16.2% |
Which Mutual Funds Hold Bayer Cropscience Ltd?
Frequently Asked Questions about Bayer Cropscience Ltd
Bayer Cropscience Ltd (BAYERCROP) closed at ₹3,717.6 on NSE on 25 September 2026, down 18.7 (0.5%) from the previous close.
Bayer Cropscience Ltd trades on the NSE (National Stock Exchange of India) under the symbol BAYERCROP.
Bayer Cropscience Ltd has a trailing twelve-month P/E (price-to-earnings) ratio of 344.0.
Bayer Cropscience Ltd has a dividend yield of 3.99%.
Bayer Cropscience Ltd's 52-week high is ₹5,150.0 and its 52-week low is ₹3,725.0.
Bayer Cropscience Ltd has a market capitalisation of ₹16,957 crore.
Bayer Cropscience Ltd has a TopFund Quality Score of 54/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Bayer Cropscience Ltd?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.